Sulfamethoxazole And Trimethoprim Tablet
NDC Package 57237-232-01
Package Information
Sulfamethoxazole And Trimethoprim tablets is to reduce the development of drug-resistant bacteria and maintain the effectiveness of sulfamethoxazole and trimethoprim tablets, USP and other antibacterial drugs, sulfamethoxazole and trimethoprim tablets, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. This formulation utilizes a tablet delivery system. Marketed by Rising Pharma Holdings, Inc., this product is identified by NDC 57237-232 and is authorized under FDA application ANDA090624.
Identification & Billing
- RxCUI: 198334 - sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet
- RxCUI: 198334 - SMX 400 MG / TMP 80 MG Oral Tablet
- RxCUI: 198335 - sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet
- RxCUI: 198335 - SMX 800 MG / TMP 160 MG Oral Tablet
Clinical Specifications
- Cytochrome P450 2C8 Inhibitors - [MoA] (Mechanism of Action)
- Cytochrome P450 2C9 Inhibitors - [MoA] (Mechanism of Action)
- Dihydrofolate Reductase Inhibitor Antibacterial - [EPC] (Established Pharmacologic Class)
- Dihydrofolate Reductase Inhibitors - [MoA] (Mechanism of Action)
- Organic Cation Transporter 2 Inhibitors - [MoA] (Mechanism of Action)
- Sulfonamide Antimicrobial - [EPC] (Established Pharmacologic Class)
- Sulfonamides - [CS]
Regulatory & Marketing
Hierarchy Structure
- 57237 - Rising Pharma Holdings, Inc.
- 57237-232 - Sulfamethoxazole And Trimethoprim
- 57237-232-01 - 100 TABLET in 1 BOTTLE
- 57237-232 - Sulfamethoxazole And Trimethoprim
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (57237-232). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 57237-232-01 identifies a specific commercial package of 100 tablet in 1 bottle of Sulfamethoxazole And Trimethoprim, a human prescription drug labeled by Rising Pharma Holdings, Inc.. This tablet is formulated for oral use and contains sulfamethoxazole; trimethoprim as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Rising Pharma Holdings, Inc. on February 16, 2010. The current certification is valid through December 31, 2026.
How is this Rising Pharma Holdings, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 57237023201. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.
